Labstyle Innovations Corp. (DRIO) 0.1945 $DRIO
LabStyle Innovations enters into tele-care partnership with Israel's Maccabi Healthcare for remote support platform for diabetes
M2 - Fri Jan 23, 8:03PM CST
Diabetes management company LabStyle Innovations (OtherOTC
RIO) disclosed on Thursday a partnership agreement to implement its comprehensive Dario digital suite for patients and professionals remote proactive care in Israel through Maccabi Healthcare.
LabStyle Innovations Announces HMO Tele-Care Partnership Agreement
PR Newswire - Thu Jan 22, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported that it has signed a partnership agreement with Israel's leading healthcare HMO; Maccabi Healthcare to implement its comprehensive Dario(TM) digital suite for patients and professionals remote proactive care.
LabStyle Innovations Appoints Zvi Ben-David as New Chief Financial Officer
PR Newswire - Thu Jan 08, 8:05AM CST
LabStyle Innovations Corp. (OTCQB RIO), developer of the Dario(TM) Diabetes Management Solution, announced today that Zvi Ben-David will be joining LabStyle as the company's new Chief Financial Officer, Treasurer and Secretary effective immediately.
LabStyle Innovations Awarded Reimbursement Status in Australia for the Dario(TM) Smart Meter Strips
PR Newswire - Wed Dec 03, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO) the maker of the Dario(TM) smart meter for diabetics announced today that it has been granted reimbursement status for its Dario(TM) blood glucose test strips to be utilized together with the patented Dario(TM) smart meter in Australia. This achievement marks another milestone in the continuing worldwide roll out of Dario(TM).
LabStyle Innovations Announces Two Board Appointments
PR Newswire - Mon Nov 24, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that Dr. Peter Kash and Ms. Hila Karah have been appointed to serve on the company's Board of Directors.
LabStyle Innovations Announces 2014 Third Quarter Results and Provides Business Update
PR Newswire - Fri Nov 14, 8:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three month period ending September 30, 2014 and provided an update on recent corporate achievements and anticipated milestones for the remainder of 2014 and 2015.
LabStyle Innovations Common Stock to Resume Trading Under the Symbol "DRIO"
PR Newswire - Wed Nov 05, 8:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that its common stock will resume trading on the OTCQB Market under the symbol "DRIO."
LabStyle Innovations implements one for five reverse stock split
M2 - Mon Oct 06, 7:20AM CDT
Diabetes management solution LabStyle Innovations (Other OTC RIO) reported on Monday the launch of a one-for-five reverse common stock split at 9:00 eastern standard time.
LabStyle Innovations Implements 1-for-5 Reverse Stock Split
PR Newswire - Mon Oct 06, 5:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that effective at 9:00 a.m. eastern standard time on October 6, 2014, the company will implement a 1-for-5 reverse stock split of the company's common stock.
LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing
PR Newswire - Tue Sep 23, 3:05PM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that it has closed a $4.2 million private placement offering consisting of shares of preferred stock and warrants. No placement agent was used for this financing. After estimated offering expenses, LabStyle expects to secure net proceeds of approximately $4.1 million from this financing.
OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc.
PR Newswire Europe - Tue Aug 19, 10:11AM CDT
LONDON, August 19, 2014 /PRNewswire/ --
LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
PR Newswire - Fri Aug 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three and six months period ending June 30, 2014. The company also presented an overview of results of the Dario(TM) smart meter soft launch, recent corporate achievements and anticipated milestones for the remainder of 2014.
LabStyle Innovations Announces the Initial Launch of the Dario(TM) Diabetes Management Solution for Android Devices
PR Newswire - Thu Jul 31, 8:50AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company has released the Dario(TM) Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario(TM) Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.
LabStyle Innovations wins Israeli Ministry of Health's approval to market the Dario Smart Meter to people living with diabetes in Israel
M2 - Tue Jul 29, 6:09AM CDT
Diabetes management company LabStyle Innovations (Other OTC RIO) disclosed on Monday the receipt of the Israeli AMAR's approval for the marketing and sale of the Dario Smart Meter in Israel.
LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario(TM) Smart Meter
PR Newswire - Mon Jul 28, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has received approval from the Israeli AMAR for the marketing and sale of the Dario(TM) Smart Meter in Israel. The Israeli AMAR is a unit in the Ministry of Health and is responsible for certification of all activities concerning medical devices import, sale and export and is a precondition for the sale of medical devices in Israel.
LabStyle Innovations Corp.'s CEO Erez Raphael Interviewed by The Life Sciences Report
Marketwire - Thu Jul 17, 8:25AM CDT
Having a chronic disease like diabetes engenders a sense of isolation that hasn't been adequately addressed by technology until now. With Dario, LabStyle Innovations Corp. (OTCQB: DRIO) has created a device that not only provides vital medical information to a diabetic patient in real time, but also connects that patient to a community of care providers, family, and online resources. In this interview with The Life Sciences Report, LabStyle President and CEO Erez Raphael describes how the Dario software platform could provide sufferers of other chronic diseases with the benefits of real-time data and community as well.
LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
PR Newswire - Thu Jul 10, 11:00AM CDT
LabStyle Innovations Corp. (OTCQB RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors.
LabStyle Innovations to distribute its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical
M2 - Thu Jul 10, 7:35AM CDT
LabStyle Innovations (OTCQB RIO), a mobile health company that provides laboratory-testing products, reported on Wednesday the launch of an exclusive distribution agreement for its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical.
LabStyle Innovations enters into tele-care partnership with Israel's Maccabi Healthcare for remote support platform for diabetes
M2 - Fri Jan 23, 8:03PM CST
Diabetes management company LabStyle Innovations (OtherOTC
RIO) disclosed on Thursday a partnership agreement to implement its comprehensive Dario digital suite for patients and professionals remote proactive care in Israel through Maccabi Healthcare. LabStyle Innovations Announces HMO Tele-Care Partnership Agreement
PR Newswire - Thu Jan 22, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported that it has signed a partnership agreement with Israel's leading healthcare HMO; Maccabi Healthcare to implement its comprehensive Dario(TM) digital suite for patients and professionals remote proactive care.
LabStyle Innovations Appoints Zvi Ben-David as New Chief Financial Officer
PR Newswire - Thu Jan 08, 8:05AM CST
LabStyle Innovations Corp. (OTCQB
RIO), developer of the Dario(TM) Diabetes Management Solution, announced today that Zvi Ben-David will be joining LabStyle as the company's new Chief Financial Officer, Treasurer and Secretary effective immediately. LabStyle Innovations Awarded Reimbursement Status in Australia for the Dario(TM) Smart Meter Strips
PR Newswire - Wed Dec 03, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO) the maker of the Dario(TM) smart meter for diabetics announced today that it has been granted reimbursement status for its Dario(TM) blood glucose test strips to be utilized together with the patented Dario(TM) smart meter in Australia. This achievement marks another milestone in the continuing worldwide roll out of Dario(TM).
LabStyle Innovations Announces Two Board Appointments
PR Newswire - Mon Nov 24, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that Dr. Peter Kash and Ms. Hila Karah have been appointed to serve on the company's Board of Directors.
LabStyle Innovations Announces 2014 Third Quarter Results and Provides Business Update
PR Newswire - Fri Nov 14, 8:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three month period ending September 30, 2014 and provided an update on recent corporate achievements and anticipated milestones for the remainder of 2014 and 2015.
LabStyle Innovations Common Stock to Resume Trading Under the Symbol "DRIO"
PR Newswire - Wed Nov 05, 8:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that its common stock will resume trading on the OTCQB Market under the symbol "DRIO."
LabStyle Innovations implements one for five reverse stock split
M2 - Mon Oct 06, 7:20AM CDT
Diabetes management solution LabStyle Innovations (Other OTC
RIO) reported on Monday the launch of a one-for-five reverse common stock split at 9:00 eastern standard time. LabStyle Innovations Implements 1-for-5 Reverse Stock Split
PR Newswire - Mon Oct 06, 5:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that effective at 9:00 a.m. eastern standard time on October 6, 2014, the company will implement a 1-for-5 reverse stock split of the company's common stock.
LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing
PR Newswire - Tue Sep 23, 3:05PM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that it has closed a $4.2 million private placement offering consisting of shares of preferred stock and warrants. No placement agent was used for this financing. After estimated offering expenses, LabStyle expects to secure net proceeds of approximately $4.1 million from this financing.
OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc.
PR Newswire Europe - Tue Aug 19, 10:11AM CDT
LONDON, August 19, 2014 /PRNewswire/ --
LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
PR Newswire - Fri Aug 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three and six months period ending June 30, 2014. The company also presented an overview of results of the Dario(TM) smart meter soft launch, recent corporate achievements and anticipated milestones for the remainder of 2014.
LabStyle Innovations Announces the Initial Launch of the Dario(TM) Diabetes Management Solution for Android Devices
PR Newswire - Thu Jul 31, 8:50AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company has released the Dario(TM) Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario(TM) Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.
LabStyle Innovations wins Israeli Ministry of Health's approval to market the Dario Smart Meter to people living with diabetes in Israel
M2 - Tue Jul 29, 6:09AM CDT
Diabetes management company LabStyle Innovations (Other OTC
RIO) disclosed on Monday the receipt of the Israeli AMAR's approval for the marketing and sale of the Dario Smart Meter in Israel. LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario(TM) Smart Meter
PR Newswire - Mon Jul 28, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has received approval from the Israeli AMAR for the marketing and sale of the Dario(TM) Smart Meter in Israel. The Israeli AMAR is a unit in the Ministry of Health and is responsible for certification of all activities concerning medical devices import, sale and export and is a precondition for the sale of medical devices in Israel.
LabStyle Innovations Corp.'s CEO Erez Raphael Interviewed by The Life Sciences Report
Marketwire - Thu Jul 17, 8:25AM CDT
Having a chronic disease like diabetes engenders a sense of isolation that hasn't been adequately addressed by technology until now. With Dario, LabStyle Innovations Corp. (OTCQB: DRIO) has created a device that not only provides vital medical information to a diabetic patient in real time, but also connects that patient to a community of care providers, family, and online resources. In this interview with The Life Sciences Report, LabStyle President and CEO Erez Raphael describes how the Dario software platform could provide sufferers of other chronic diseases with the benefits of real-time data and community as well.
LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
PR Newswire - Thu Jul 10, 11:00AM CDT
LabStyle Innovations Corp. (OTCQB
RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors. LabStyle Innovations to distribute its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical
M2 - Thu Jul 10, 7:35AM CDT
LabStyle Innovations (OTCQB
RIO), a mobile health company that provides laboratory-testing products, reported on Wednesday the launch of an exclusive distribution agreement for its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical. 
